Skip to content
healthcare.dev

Nelarabine

NDC 39822-0650, Nelarabine, injection, from XGen Pharmaceuticals DJB, Inc..

Product NDC
39822-0650
Status
Listed
Labeler
XGen Pharmaceuticals DJB, Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216510
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/39822-0650 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NELARABINE5 mg/mL

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
39822-0650-1398220650011 VIAL in 1 CARTON (39822-0650-1) / 50 mL in 1 VIAL
39822-0650-6398220650066 VIAL in 1 CARTON (39822-0650-6) / 50 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a1cc1580-50d9-4b9b-a002-1fc6686a9515
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=39822-0650

Use it

Look up 39822-0650 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/39822-0650 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 39822-0650. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.